Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Trials|August 7, 2019
Update to the study protocol, including statistical analysis plan, for the multicentre, randomised controlled OuTSMART trial: a combined screening/treatment programme to prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodiesDominic Stringer, Leanne M Gardner, Janet L Peacock, et al.
Medrxiv : the Preprint Server for Health Sciences|June 26, 2025
Inborn errors of immunity: manifestation, treatment, and outcome - an ESID registry 1994-2024 report on 30,628 patientsGerhard Kindle, Mickaël Alligon, Michael H Albert, et al.
Eclinicalmedicine|January 23, 2023
Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trialDominic Stringer, Leanne Gardner, Olivia Shaw, et al.
Journal of Human Immunity|December 5, 2025
Inborn errors of immunity: Manifestation, treatment, and outcome-an ESID registry 1994-2024 report on 30,628 patientsGerhard Kindle, Mickaël Alligon, Michael H Albert, et al.
The Journal of Allergy and Clinical Immunology. Global|April 25, 2025
Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitorMarkus Magerl, Marc A Riedl, Luisa Karla Arruda, et al.
Clinical Immunology (Orlando, Fla.)|February 18, 2025
Ex vivo T-lymphopoiesis assays assisting corrective treatment choice for genetically undefined T-lymphocytopeniaZainab M Golwala, Helena Spiridou Goncalves, Ranjita Devi Moirangthem, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 5, 2023
A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United KingdomPatrick F K Yong, Tanya Coulter, Tariq El-Shanawany, et al.
Frontiers in Immunology|March 31, 2018
Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome RegistryMaria Elena Maccari, Hassan Abolhassani, Asghar Aghamohammadi, et al.
Pageof 4